C21 Investments Inc. (CSE:CXXI)

Market Cap	63.60M
Revenue (ttm)	43.75M
Net Income (ttm)	-4.52M
Shares Out	117.77M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	258,490
Average Volume	94,869
Open	0.5100
Previous Close	0.4900
Day's Range	0.5000 - 0.5400
52-Week Range	0.1500 - 0.5700
Beta	2.55
RSI	72.74
Earnings Date	Aug 15, 2025

About C21 Investments

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 138
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CXXI

Financial Performance

In 2024, C21 Investments's revenue was $30.12 million, an increase of 12.42% compared to the previous year's $26.79 million. Losses were -$3.97 million, 789.2% more than in 2023.

Financial numbers in USD